BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190910
DTEND;VALUE=DATE:20190914
DTSTAMP:20260515T052105
CREATED:20190607T133410Z
LAST-MODIFIED:20190607T133524Z
UID:21126-1568073600-1568419199@www.pharmajournalist.com
SUMMARY:5th Annual CAR-TCR Summit
DESCRIPTION:The definitive\, world-renowned summit dedicated to providing comprehensive insight into the full end-to-end pharmaceutical value chain for CAR-TCR therapies in liquid and solid tumor indications. \nThe CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR and TCR therapy development. \n \nDedicated to discussing the next generation candidates beyond CD19\, from solid tumor indications to autoimmune disorders\, this meeting provides an in depth breakdown of the current strategies to optimize the durability\, persistence and targeting of approved and novel therapies to reduce relapse rates and overcome toxicity. \nAt the premier\, end-to-end summit focused on early research through to commercialization\, join the experts to discuss how to streamline process development and logistics supply chains for affordable and accessible CAR-TCR therapeutics. \nTake advantage of the unrivalled networking opportunities as we bring together over 1000 industry leaders developing CAR-TCR based therapies from across pharma\, biotech\, regulatory bodies\, academia\, solution and service providers. \nHere’s a snapshot of the 140+ world class speaker faculty: \n\nJames Noble\, Chief Executive Officer\, Adaptimmune\nBarbra Sasu\, Chief Scientific Officer\, Allogene\nChris Haqq\, Chief Scientific Officer\, Atara Biotherapeutics\nElsy Boglioli\, Chief Operating Officer\, Cellectis\nJean-Pierre Latere\, Chief Operations Officer\, Celyad\nKatherine Szarama\, Evidence Development Division\, Coverage & Analysis Group\, Center for Clinical Standards and Quality\, Centers for Medicare & Medicaid Services\nCheng Liu\, Chief Executive Officer\, Eureka Inc.\nJason Krentz\, Chief Technology Officer\, Tmunity Therapeutics\nThomas Andresen\, Chief Scientific Officer\, Torque Therapeutics\nMatthew Spear\, Chief Medical Officer\, Poseida Therapeutics\n\nDownload the event guide for the full details of the speaker line-up\, agenda and discounts available.
URL:https://www.pharmajournalist.com/event/5th-annual-car-tcr-summit/
LOCATION:Seaport Hotel & World Trade Center\, One Seaport Lane\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190910
DTEND;VALUE=DATE:20190912
DTSTAMP:20260515T052105
CREATED:20190522T082604Z
LAST-MODIFIED:20190522T082604Z
UID:20829-1568073600-1568246399@www.pharmajournalist.com
SUMMARY:Pharma and Device Packaging and Labelling Europe 2019
DESCRIPTION:After a successful European launch\, a special thank you to all our attendees at the Pharma Packaging and Labelling Conference! Arena International is delighted to announce we will be returning to Munich in 2019 for another superb year. \nWe have welcomed more than 100 attendees from across the region for two days of engaging presentations from the biggest names in the sector. \nThe 2018 programme looked at ongoing regulations\, ensuring patient safety and making sure the right systems are in place which is more crucial than ever with the ever looming FMD regulations. Top pharmaceutical companies\, biotechs\, CMOs and medical device companies such as Abbott\, Sandoz\, Coloplast\, AbbVie\, Novartis\, Roche; including regulatory bodies GS1\, EAASM and many more came together to share their insights into compliant packaging and labelling implementation. \nPharma Packaging and Labelling Europe will be returning in September 2019. We look forward to seeing you all there!
URL:https://www.pharmajournalist.com/event/pharma-and-device-packaging-and-labelling-europe-2019/
LOCATION:Munich\, Germany
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190904
DTEND;VALUE=DATE:20190907
DTSTAMP:20260515T052105
CREATED:20190708T094531Z
LAST-MODIFIED:20190708T094531Z
UID:21492-1567555200-1567814399@www.pharmajournalist.com
SUMMARY:3D Tissue Models Summit
DESCRIPTION:The 3D Tissue Models Summit will bring together 120+ industry stakeholders across the regulatory\, pharma\, biotech and academic landscapes to discuss the latest insight into established validation techniques to increase reproducibility and improve the preclinical effectiveness of drug candidates. \nJoin us and discover: \n20+ latest case studies showcasing the advantages of high throughput screening techniques across the 3D model continuum to drive drug discovery progress. \nFDA guidance into the regulatory landscape to define a common language of key terms across the industry for end users. \nNIH and IQ Consortia discussing the latest developments to incorporate platform-specific standardization and reproducibility metrics for organoids and tissue chip technology. \nModel developers and academic experts revealing how to overcome translational challenges to define disease-relevant endpoints across a variety of model types. \nTake advantage of this unrivalled learning and networking opportunity packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways to enhance the predictive success of your preclinical 3D models.
URL:https://www.pharmajournalist.com/event/3d-tissue-models-summit/
LOCATION:Hilton Boston Back Bay  40 Dalton St  Boston\, MA  02115\, USA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190904
DTEND;VALUE=DATE:20190907
DTSTAMP:20260515T052105
CREATED:20190529T085545Z
LAST-MODIFIED:20190529T090758Z
UID:20888-1567555200-1567814399@www.pharmajournalist.com
SUMMARY:2nd Microbiome Movement - Skin Health & Dermatology Summit
DESCRIPTION:2nd Microbiome Movement – Skin Health & Dermatology Summit\nTranslate the Skin Microbiome into Safe\, Effective & Commercially Viable Dermatological Therapeutics & Cosmetic Products\n4-6 September 2019 | San Diego\nWebsite: https://ter.li/bsl3rt \nAs scientific researchers continue to investigate the complexities of the skin microbiome\, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic\, dermatological & cosmetic researchers\, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics). \n \nOur conversations have highlighted that although a strong commercial opportunity exists\, there are critical areas of basic science that need addressing including study design to elucidate host-microbiome interactions\, selecting the right tools to make clear correlations between microbial dysbiosis and skin disease and standardization of sample collection and analysis. \nIf you’re keen to make sense of skin microbiome science and its application to the therapeutic and cosmetic industry\, join over 100+ scientifically-driven researchers from academia\, biopharma and the cosmetic community to help you discover\, translate and commercialize breakthrough therapeutics or cosmetics that improve skin health. \nEarly booking and group discounts are available. Visit the website to learn more: https://ter.li/bsl3rt
URL:https://www.pharmajournalist.com/event/2nd-microbiome-movement-skin-health-dermatology-summit/
LOCATION:The Westin San Diego\, 400 West Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190827
DTEND;VALUE=DATE:20190830
DTSTAMP:20260515T052105
CREATED:20180531T135859Z
LAST-MODIFIED:20190430T084109Z
UID:16049-1566864000-1567123199@www.pharmajournalist.com
SUMMARY:3rd Annual IPF Summit
DESCRIPTION:The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics. \n \nWith the 2019 conference expanding upon an even greater breadth and depth of content\, you’ll hear three days of unrivalled scientifically driven and case-study based analysis and discussion\, as together leading academia and biopharma advance the IPF drug development frontier. \nLast year\, over 90 of IPF’s expert drug developers came together to advance the standardisation of imaging\, share clinical insights\, and evaluate better recapitulating disease physiology in vitro exclusively for IPF: \n“This was a superb meeting combining several emerging themes in IPF therapies and a dynamic mix of formal presentations with impromptu networking. All the speakers were excellent\, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!” \nCeders-Sinai Medical Center \nWith the incredible breakthrough success of drugs now in our arsenal for slowing IPF disease progression\, the increasing importance of identifying genetic mechanisms\, closing the translational gap between preclinical and clinical results\, and developing candidates to reverse fibrosis have opened up further challenges within IPF drug development. \nJoin “part 3” as the IPF community converges again to: \n\nAnalyze the latest understanding of IPF pathology for improved target validation of next generation therapeutics and the potential to promote tissue regeneration to achieve reversal of fibrosis\nCritically discuss how to design the next generation of phase III clinical trials for candidate success in light of a current standard of care\nOutline progressions in the standardization of imaging and advancements of biomarkers to improve translational success and more confident diagnosis of patients\n\nTo learn more about 3rd Annual IPF Summit and to register online\, visit https://ter.li/i81anp \nContact \nEmail – info@hansonwade.com\nPhone – +1 415 735 3289
URL:https://www.pharmajournalist.com/event/ipf-summit/
LOCATION:Sheraton San Diego Hotel & Marina\, 1380 Harbor Island Drive\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190822
DTEND;VALUE=DATE:20190824
DTSTAMP:20260515T052105
CREATED:20190531T125458Z
LAST-MODIFIED:20190531T125545Z
UID:21020-1566432000-1566604799@www.pharmajournalist.com
SUMMARY:4th Annual Medical Device Regulatory and Quality Summit 2019
DESCRIPTION:4th Annual Medical Device Regulatory and Quality Summit 2019 will create a platform for regulators\, industry stalwarts to come under one roof to discuss and share ideas that would not only benefit their organisations\, but at large the industry as well. The 4th Annual Medical Device Regulatory and Quality Summit 2019 will review the evolving regulations\, their impact on the industry as well as take an in depth look into areas of quality control and assurance. \n \nTo learn more about this event\, and to register online\, visit http://bit.ly/2MgH15z
URL:https://www.pharmajournalist.com/event/4th-annual-medical-device-regulatory-and-quality-summit-2019/
LOCATION:New Delhi\, India
ORGANIZER;CN="Inventicon Business Intelligence":MAILTO:pooja.mishra@inventicon.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190820
DTEND;VALUE=DATE:20190823
DTSTAMP:20260515T052105
CREATED:20190529T091738Z
LAST-MODIFIED:20190529T091738Z
UID:20911-1566259200-1566518399@www.pharmajournalist.com
SUMMARY:2nd Annual Hemophilia Drug Development Summit
DESCRIPTION:Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapies\, the 2nd Annual Hemophilia Drug Development Summit\, once again unites leading pharma\, biotech and academic KOLs working to translate and clinically develop longer acting and more efficacious therapies to overcome significant unmet medical need and hemophilia and other bleeding disorders. \n \nAttend the 2nd Hemophilia Drug Development Summit to identify novel drug development strategies and overcome the shared translational\, clinical development and delivery challenges to dramatically improve patient outcomes. \nSounds interesting? Find out more – get free event brochure here: https://ter.li/4snxn9
URL:https://www.pharmajournalist.com/event/hemophilia-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190813
DTEND;VALUE=DATE:20190816
DTSTAMP:20260515T052105
CREATED:20190530T091644Z
LAST-MODIFIED:20190530T091644Z
UID:20938-1565654400-1565913599@www.pharmajournalist.com
SUMMARY:B3DD Summit
DESCRIPTION:The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates. \n \nWith an emphasis on biologics\, and built with the field’s leading minds from the likes of Biogen\, Genentech\, Armagen & Denali\, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development. \nSome of the highlights include: \n\nAssessing Microphysiological Models of the BBB – Biogen\nEmploying in vivo Microdialysis & Microperfusion Methods to Understand Brain Disposition of Biologics for the Treatment of CNS Disorders – AbbVie\nClinical Efficacy of Antibody-enzyme Fusion Proteins as Carrier Platform to Transport Lysosomal Enzymes Across the BBB for the Treatment of Mucopolysaccharidosis Type I\nPKPD of Different Therapeutic Modalities for CNS Indications – Genentech\nExplaining Clinical Failures – Is Efficacy or Delivery to Blame?- Merck\, Lundbeck\, AbbVie\n\nTo learn more about B3DD Summit\, and to register online\, visit https://ter.li/7vs04e
URL:https://www.pharmajournalist.com/event/b3dd-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190723
DTEND;VALUE=DATE:20190726
DTSTAMP:20260515T052105
CREATED:20190404T071545Z
LAST-MODIFIED:20190404T071545Z
UID:20177-1563840000-1564099199@www.pharmajournalist.com
SUMMARY:2nd Neuropsychiatric Drug Development Summit
DESCRIPTION:THE INDUSTRY’S DEFINITIVE MEETING TO ADVANCE THE DEVELOPMENT OF CLINICALLY TRANSFORMATIVE NEUROPSYCHIATRIC DRUGS \n \nWith the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available\, the development of the next generation of neuropsychiatric drugs is essential. \nThe abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the Neuropsychiatric Drug Development summit\, in Boston on July 23 – 25\, 2019. \nBuilt with thought-leaders at Sage Therapeutics\, Johnson & Johnson and Lundbeck\, the 2nd Annual NPD summit will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs. \nDedicated to overcoming challenges in neuropsychiatric drug development\, this comprehensive discussion and networking forum will cover: \n\nReviewing the current clinical landscape to share learned lessons\, predict potential success and identify future opportunities\nDetermine what we can expect from neuropsychiatric preclinical models to better predict clinical efficacy\nUtilize what we know from the clinical to improve our use of translational strategies\nDiscuss the potential for digital therapeutics to transform the success of efficacious pharmaceuticals\nReview symptomatic focused drug development to identify the benefits and impact future regulation\nEvaluate the potential for different neuropsychiatric targets by improving our understanding of neuropsychiatric biology\nImproving our understanding of the role of genetics in neuropsychiatry and debating the future of precision medicine for neuropsychiatric disorders\n\nJoin your peers at NPD to be part of the cross-industry discussion on latest developments\, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines \nTo learn more about this event\, visit https://ter.li/belugv
URL:https://www.pharmajournalist.com/event/2nd-neuropsychiatric-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260515T052105
CREATED:20190617T102853Z
LAST-MODIFIED:20190617T102853Z
UID:21229-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:IMPACCT: mHealth in Clinical Trials Summit
DESCRIPTION:The IMPACCT: mHealth in Clinical Trials series provides a dedicated forum for industry leaders in clinical and digital innovation to share data\, best practice and game-changing approaches on how to transform the clinical research paradigm with digital technology and achieve true patient-centricity. \nJoin your peers and leading experts in this space for a collaborative discussion aiming to tackle key implementation challenges and accelerate the successful incorporation of innovative digital strategies in clinical R&D\, to enhance patient experience and outcomes. \nIndustry leaders already confirmed include Novartis\, AbbVie\, the DiMe Society\, Verily & many others.
URL:https://www.pharmajournalist.com/event/impacct-mhealth-in-clinical-trials-summit/
LOCATION:The Westin Copley Place Boston\, 10 Huntington Ave\, Boston\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260515T052105
CREATED:20190424T121423Z
LAST-MODIFIED:20190424T121423Z
UID:20441-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:PREDiCT: Tumor Models Boston
DESCRIPTION:The 7th Annual PREDiCT: Tumor Models Boston summit will explore robust preclinical strategies utilizing current and emerging model systems to overcome core challenges across the early stages of cancer drug development. Presentations will span preclinical strategies validating new anticancer drugs\, assessing therapeutic index and identifying surrogate markers of tumor progression. \n \nPlug into a network of preclinical and translational scientists seeking to share methods for the rational design of combinations\, patient stratification and identify new strategies to model metastasis\, resistance and sensitivity. \nWhy attend PREDiCT : Tumor Models Boston ? \n\n35+ Preclinical & Translational Oncology Heads\, each pioneering the further development and application of experimental models\, will be sharing the latest insights on the impact of their work.\n100+ senior level scientists from Sanofi\, Kleo Pharmaceuticals\, NIH\, Dicerna\, Pfizer\, Crown Bioscience\, The Jackson Laboratory\, Eisai and many more are set to review the comparative cost-per-data point of next generation models alongside classical model-systems.\nWe’ll explore how classical and emerging models are evolving efficacy determination\, biomarker discovery and combination therapies\, allowing you to further develop your research and gain the best insight of the industry.\n\nDownload the full event guide to find out more! \nTo learn more about this event\, and to register online\, visit https://tumor-models.com/
URL:https://www.pharmajournalist.com/event/predict-tumor-models-boston/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260515T052105
CREATED:20190204T112557Z
LAST-MODIFIED:20190204T113033Z
UID:19372-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:Indian Pharma Expo & Business Excellence Award 2019
DESCRIPTION:CIMS Medica presents the 8th edition of Indian Pharma Expo (IPE)\, scheduled to be held on 16th-18th July\, 2019 at Hall No. 12-A\, Pragati Maidan\, New Delhi. \n \nPrevious year IPE set another successful milestone with presence of visitors from all parts of India and provided a common platform for promising sellers and potential buyers from Pharmaceutical and Healthcare Industries. With IPE\, the benefits are bound to get augmented with presence of eminent personalities from various sectors of Pharma\, non-pharma and healthcare industries. It will gather representation from various companies like Pharmaceutical manufacturers & marketers\, packaging solution providers\, machinery solution providers\, franchise companies and many more under one roof. \nThe 3-day expo will bring together eminent personalities from various sectors of Pharmaceutical\, non-pharma and healthcare industries. IPE 2019 is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnel who seek to buy bulk products on concessional rates. \nThis year IPE will be one point contact to exchange the business opportunities for National and International Pharmaceutical Companies. This event will prove to be a business expansion tool to many small-medium-major players in Pharmaceutical Industry.
URL:https://www.pharmajournalist.com/event/indian-pharma-expo-business-excellence-award-2019/
LOCATION:Hall no. 12-A\, Pragati Maidan\, New Delhi\, Delhi\, India
ORGANIZER;CN="CIMS Medica India Pvt Ltd":MAILTO:ipe@cims.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190710
DTEND;VALUE=DATE:20190712
DTSTAMP:20260515T052105
CREATED:20190522T082202Z
LAST-MODIFIED:20190522T082202Z
UID:20825-1562716800-1562889599@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials to East Coast 2019
DESCRIPTION:Arena International is excited to announce the return of the 7th Annual Clinical Operations in Oncology Trials to the East Coast on July 10th-July 11th 2019. \nAs one of the only oncology operationally focused events in the East Coast\, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage East Coast physicians and patients. \nThe event will be led by a myriad of industry specialists from the East Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion\, spotlight Q&As\, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market. \nWhile maintaining the primary focus of its previous years\, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry\, and provide insight into the latest technological and therapeutic solutions. \nThis July prepare to hear from  industry leading oncologists about accurate abidance to ICH E8 guidelines\, effective oversight strategies\, efficient trial designs and data management solutions. As pharmaceutical companies shift to conducting immuno-oncology trials and look towards how AI\, data analytics and cutting edge technology can aid with early diagnosis\, take this opportunity to stay updated with industry trends and showcase your innovative solutions to key decision makers. \nWe hope to see you in July\, make sure to register your place today!
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials-to-east-coast-2019/
LOCATION:Boston\, Massachusetts
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190627
DTSTAMP:20260515T052105
CREATED:20190409T072829Z
LAST-MODIFIED:20190409T072829Z
UID:20257-1561507200-1561593599@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27\, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.  \n\nThe Pharma Gorilla | June 26\, 2019 | Le Meridien Singapore\, Sentosa\nThe Pharma Gorilla | Nov 07\, 2019 | New Delhi\, India\n\n The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe conference program have been designed in such way which can cover the trending topics under Keynote session\, exclusive presentation\, product lunch\, panel and round table discussion and it also provides a meaningful information. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition. \nTarget Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies\, software development companies\, CRO\, manufacturing\, formulation\, digital marketing and data management companies. \nGlimpse of Conference Agenda! \n Conference Panels \n\nArtificial Intelligence in Pharma and Healthcare\nA disruptive take on marketing: Digital Marketing comes to Pharma\nScope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry\nLatest Trends in Formulation Development: A Global Perspective\nThe Impact of Regulatory Reform on Innovation in Drug Delivery Systems\n\nRoundtable Discussion \n\nImproving patient engagement and experience to improve clinical trials\n\n Keynote Session \n\nInnovation-driven and emerging technologies of Pharma Industry in Asia\nThe Global Pharma Industry: Policies\, Regulations and Key Trends 2019-2020\n\nExclusive Presentation \n\nRole of IPR in pharmaceutical industry\nCareer Growth Opportunities in the pharmaceutical industry\nImproving Biosimilars in manufacturing data\n\nFor any query\, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla-2/
LOCATION:Le Meridien Singapore\, Sentosa
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190629
DTSTAMP:20260515T052105
CREATED:20190225T142502Z
LAST-MODIFIED:20190225T142702Z
UID:19737-1561507200-1561766399@www.pharmajournalist.com
SUMMARY:4th Microbiome Movement – Drug Development Summit
DESCRIPTION:4th Microbiome Movement – Drug Development Summit\nJune 26-28\, 2019 | Boston\, MA \n \nReturning for the fourth year\, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical\, biotech and academic community pursue the causal role of the human microbiome in disease\, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs. \nIf you are\, or would like to be\, a player in the microbiome arena\, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics\, biomarkers and diagnostics\, but also make long-lasting connections that will accelerate your microbiome developments forward\, and help translate this promising science into a reality for patients. \nHear from 60+ expert speakers including: \n\nAlison Lawton\, CEO\, Kaleido Biosciences\nBernat Olle\, CEO\, Vedanta Biosciences\nCathryn Nagler\, Bunning Food Allergy Professor\, University of Chicago\nEric Shaff\, CEO\, Seres Therapeutics\nEsi Lamouse-Smith\, Director\, Janssen Pharmaceuticals\nKen Blount\, CSO\, Rebiotix\nMike Romanos\, CEO\, Microbiotica\nUlrich Thienel\, Chief Medical Officer\, Finch Therapeutics Group\n\nSee the complete agenda and speaker list: https://ter.li/nefsqj \nEarly booking rates and group discounts are available. Visit the website to learn more: https://ter.li/1bcb5n.
URL:https://www.pharmajournalist.com/event/4th-microbiome-movement-drug-development-summit/
LOCATION:Revere Boston Common Hotel\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260515T052105
CREATED:20190426T082151Z
LAST-MODIFIED:20190426T082638Z
UID:20510-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:Cell Engager Summit
DESCRIPTION:The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic. \n \nOvercome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug. \nDiscover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies. \nWith 22+ hours of content\, 2 interactive workshops and over 5 hours of networking with key industry leaders\, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges. \nJoin us as we unite experts from across large pharma\, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies. \nTo learn more and to register online\, visit cell-engager-summit.com
URL:https://www.pharmajournalist.com/event/cell-engager-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260515T052105
CREATED:20190418T090640Z
LAST-MODIFIED:20190418T090640Z
UID:20372-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:2nd Combination Products Lifecycle Management Summit
DESCRIPTION:Returning to Boston for its 2nd successful year in 2019\, the CPLM Summit features a fresh speaker line-up including the FDA\, Alnylam\, kaleo\, Novartis and many others\, as well as a pre-conference focus day to give you a comprehensive LCM guide to your combination products. \n \nLifecycle management for drug-device combination product has stolen the spotlight amongst pharma\, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is a lot of potential and many benefits to having such a mind-set and implementing a robust LCM program from the get-go. \nAs the only peer-led community\, we will bring in 100+ senior leaders from drug-device teams including the regulatory affairs\, product development and quality to share their view and encourage collaborative efforts. \nFor more information on 2nd Annual CPLM Summit\, visit https://ter.li/11hr26
URL:https://www.pharmajournalist.com/event/2nd-annual-cplm-summit/
LOCATION:Hyatt Regency Boston\, One Ave. de Lafayette\, Boston\, MA\, 02111\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190624
DTEND;VALUE=DATE:20190627
DTSTAMP:20260515T052105
CREATED:20190326T120821Z
LAST-MODIFIED:20190326T121125Z
UID:20086-1561334400-1561593599@www.pharmajournalist.com
SUMMARY:GI Inflammatory Diseases Summit (GIIDS)
DESCRIPTION:Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases \nThe GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease. \nIncorporating insights from leading pharma and pioneering biotech\, this discussion and networking forum will curate the cutting edge insights on: \n\nImproving drug safety profiles of more gut-selective compounds\nOptimizing trial design in a hypercompetitive market\nThe promise of microbiome based biotherapeutics\n\nJoin gastroenterology\, immunology and anti-inflammatory drug developers at this unique conference and push the clinical frontier nearer to achieving significant clinical remission in larger groups of patients.
URL:https://www.pharmajournalist.com/event/gi-inflammatory-diseases-summit-giids/
LOCATION:Revere Hotel Boston Common  200 Stuart Street  Boston\, MA\, 02116  USA\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190619
DTEND;VALUE=DATE:20190622
DTSTAMP:20260515T052105
CREATED:20190220T075016Z
LAST-MODIFIED:20190220T075016Z
UID:19657-1560902400-1561161599@www.pharmajournalist.com
SUMMARY:8th Annual HPAPI Summit
DESCRIPTION:Enabling Robust\, Safe and Cost-Effective Productionof Highly Potent APIs \nIn the context of ever-increasing drug potency\, the 8th Annual HPAPI Summit will provide you with real-world case-studies from the companies actively working with these compounds\, enabling you to implement safe and robust practices in your own organization. \nIncorporating insights from Genentech\, Pfizer\, Boehringer Ingelheim\, SafeBridge and AbbVie\, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly\, safely and cost-effectively.
URL:https://www.pharmajournalist.com/event/8th-annual-hpapi-summit/
LOCATION:The Westin Waltham Boston  70\, Third Avenue  Waltham\,Boston  Massachusetts 02451
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190618
DTEND;VALUE=DATE:20190621
DTSTAMP:20260515T052105
CREATED:20181113T085750Z
LAST-MODIFIED:20181128T092809Z
UID:18371-1560816000-1561075199@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China 2019
DESCRIPTION:As the most comprehensive pharmaceutical exhibition in Asia\, CPhI & P-MEC China has\, since its launch in 2001\, been fostering international pharmaceutical business exchanges and leading market trends and technical innovations in the entire industry. Based in Shanghai and with a global vision\, CPhI & P-MEC China is emanating its influences by creating a trading & sourcing platform\, gathering quality suppliers\, sharing cutting-edge knowledge\, and building up an elite pharma professional network. \n \nCPhI & P-MEC China 2019 will be held in Shanghai on June 18-20\, 2019. The annual pharma gala are expected to gather 70\,000+ visits and showcase 3\,200+ exhibitors in a 200\,000+ square metre space. Welcome to join us in CPhI & P-MEC China 2019! \n  \nTo learn more and to register online\, visit: http://bit.ly/2r8jnuD
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-2019/
LOCATION:SNIEC\, Shanghai\, China
ORGANIZER;CN="UBM":MAILTO:Yingqi.shi@ubmsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190605
DTEND;VALUE=DATE:20190607
DTSTAMP:20260515T052105
CREATED:20190522T081845Z
LAST-MODIFIED:20190522T081845Z
UID:20818-1559692800-1559865599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Southern California 2019
DESCRIPTION:Facilitating a platform for the San Diego biotech hub to refine their clinical trial supply strategy to remain patient focused whilst staying at the forefront of an ever-changing landscape. \n2019 will celebrate the 9th year Arena International brings the global Clinical Trial Supply series to San Diego\, giving decision makers from small\, medium and large pharmaceutical companies the opportunity to as inject agility\, transparency and speed into your clinical trial supply. \nThis event brings the unique San Diego biotech hub together to discuss the best methodologies for ensuring successful clinical trial supply. We will focus on the full supply chain\, starting with the front end all the way to site and direct to patient delivery. Delving into the finer details we will ensure the smooth running of trial supplies\, to not only start and finish on time\, but also to meet budgetary constraints. \nAvoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions\, roundtables\, fireside chats and case studies to give rise to innovation solutions to existing challenges. \nThe key topics to be addressed will be: \n\nForecasting and Planning\nPackaging and Labelling\nUnique trial design e.g. adaptive\, compassionate use and at home delivery\nBrexit\nNew technologies\n\nJoin us in June in San Diego to be a part of the discussions and develop unique insight for clinical trial supply.
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-southern-california-2019/
LOCATION:Marriot Del Mar\, San Diego\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190604
DTEND;VALUE=DATE:20190607
DTSTAMP:20260515T052105
CREATED:20171216T022447Z
LAST-MODIFIED:20190404T074100Z
UID:5446-1559606400-1559865599@www.pharmajournalist.com
SUMMARY:Digital Pharma Europe
DESCRIPTION:The 11th Digital Pharma Europe\, hosted by Meck Serono in Rome\, will focus on helping pharma understand how to evolve and adapt to the rapidly changing global healthcare ecosystem\, and to the rapidly changing needs and dynamics of its customers. In essence: Understand Digital Marketing and the Evolution of The Engagement Model In The Era of AI. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2UrQr1e
URL:https://www.pharmajournalist.com/event/digital-pharma-europe/
LOCATION:Merck Serono Headquarters\, Via Casilina 125\, Rome\, 00176\, Italy
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190605
DTSTAMP:20260515T052105
CREATED:20190228T102509Z
LAST-MODIFIED:20190228T102724Z
UID:19778-1559520000-1559692799@www.pharmajournalist.com
SUMMARY:Lyophilisation
DESCRIPTION:SMi Presents their 7th Annual Lyophilisation Conference \nSMi Group announces the return of the 7th Annual Lyophilisation Conference taking place on the 3rd and 4th June 2019\, in London\, UK. \n \nLyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020\, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion. \nAttend this conference along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science\, materials characterisation\, novel and alternative technologies\, mathematical modelling and regulatory updates. \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \nCHAIRS FOR 2019  \nSune Klint Andersen\, Principal Spray Drying\, Janssen Pharmaceuticals \nXiaodong Chen\, Senior Research Investigator\, Bristol-Myers Squibb \nKEY SPEAKERS INCLUDE: \n\nPaul Matejtschuk\, Principal Scientist & Section Head\, Standardisation Science\, NIBSC\nDavide Fissore\, Associate Professor\, Politecnico di Torino\nMichael Dekner\, Head Fill & Finish LCM support\, Takeda\nRichard Denk\, Head Sales Containment\, Skan AG\nMostafa Nakach\, Head of Pharmaceutical Engineering Group\, Sanofi-Aventis R&D\nDaryl Williams\, Professor of Particle Science and Director of Discovery space\, Imperial College London\nKevin Ward\, Director of R&D\, Biopharma technology\nPaul Barry\, Development Scientist\, Genzyme Ireland Ltd/Sanofi\n\n2019 HIGHLIGHTS \n\nExplore the recent advances in lyophilisation methods and technologies from Biopharma Technology\nDiscuss the novel methods that characterise complex pharmaceutical products to aid formulation design from NIBSC\nGain insight into the approaches to avoid cross contamination during lyophilisation from SKAN AG\nDiscover a new approach towards process design through the use of micro freeze dryers by Politecno di Torino\nExamine the use of model-based approach to lyophilisation cycle design from Takeda\n\nFor more information on 7th Annual Lyophilisation Conference\, visit: www.lyophilisation-europe.com/PJ \nEarly-Bird Rates \n\nBOOK BY 29TH MARCH AND SAVE £400\nBOOK BY 30TH APRIL AND SAVE £200\nBOOK BY 31ST MAY AND SAVE £100\n\nContact Info\nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/lyophilisation-conference-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190529
DTEND;VALUE=DATE:20190531
DTSTAMP:20260515T052105
CREATED:20180206T133206Z
LAST-MODIFIED:20190516T105109Z
UID:9281-1559088000-1559260799@www.pharmajournalist.com
SUMMARY:Skin Microbiome Congress
DESCRIPTION:Skin Microbiome Congress\nRevere Hotel Boston Common 200 Stuart St\, Boston\, MA 02116\, USA\n29 – 30 May\, 2019 \n“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!” – Mike Conti\, Solabia \n \n2018 saw the microbiome move to the forefront of over 300 industry leaders\, who came together to exchange ideas at our Global Skin Microbiome Congress Series\, the first dedicated congress focusing solely on Skin Microbiome. \nWith the microbiome set to be the biggest trend in skincare for 2019\, we are incredibly excited to bring our flagship congress back to Boston\, building on our success globally and connecting over 300 industry leaders. \nThis year\, we take a deep-dive into the two key areas critical for success in this in this evolving field\, with our 2 concurrent tracks of content. Track 1 will focus on developing a functional understanding of the microbiome\, whereas track 2 will be focusing on building a commercial viable business. \nDon’t miss the opportunity to join leading industry experts to explore next steps for skin microbiome research and development\, as well as commercialization. \nThe inaugural Skin Microbiome Congress in 2018 SOLD OUT\, don’t miss your chance to attend this year’s event! \nTo learn more about Skin Microbiome Congress\, and to register online\, visit www.skinmicrobiomecongress.com
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190528
DTEND;VALUE=DATE:20190530
DTSTAMP:20260515T052105
CREATED:20190417T100847Z
LAST-MODIFIED:20190417T100847Z
UID:20361-1559001600-1559174399@www.pharmajournalist.com
SUMMARY:Healthcare Market Access & Pricing World Summit
DESCRIPTION:The 2nd annual Healthcare Market Access & Pricing Summit is the meeting place for the Healthcare Pricing\, Market Access\, Reimbursement\, HEOR\, and RWE community. \nSenior level experts from companies such as Abbott\, Merck\, Allergan\, and Johnson & Johnson among others will give you valuable insights through various interactive sessions. \nWith hot session topics like biosimilars\, orphan drugs and rare diseases\, this conference will provide a total and complete insight into the latest developments in the healthcare space\, may it be Pharma\, MedTech\, Biopharma or Biotech. \nJoin over 60+ healthcare professionals in May\, and book your ticket now!
URL:https://www.pharmajournalist.com/event/healthcare-market-access-pricing-world-summit/
LOCATION:NH Frankfurt Airport West Kelsterbacher Str. 19\, 65479 Germany
ORGANIZER;CN="Engaged Communications":MAILTO:sales@encom-global.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190524
DTSTAMP:20260515T052105
CREATED:20190213T123725Z
LAST-MODIFIED:20190213T124118Z
UID:19536-1558569600-1558655999@www.pharmajournalist.com
SUMMARY:Microbiome Invest
DESCRIPTION:Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors\, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
URL:https://www.pharmajournalist.com/event/microbiome-invest-2/
LOCATION:London (Venue TBC)
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190525
DTSTAMP:20260515T052105
CREATED:20190118T101935Z
LAST-MODIFIED:20190118T101935Z
UID:19147-1558569600-1558742399@www.pharmajournalist.com
SUMMARY:RE•WORK Deep Learning in Healthcare Summit\, Boston
DESCRIPTION:The Deep Learning in Healthcare Summit is returning to the east coast for the annual event in Boston! Hear from healthcare industry leaders\, academics\, researchers\, and innovative startups working to advance deep learning technology and apply this within the health sector. Focusing on topics such as medical imaging\, diagnostics\, personalized medicine and how these are applied within pharmaceuticals\, patient care\, and health and wellbeing. The summit is a great way to discover the latest insights\, evaluate your position within the industry and learn how the impacts can affect yourself and your work and provides an opportunity to network with other valued members of the community. \nDiscount Code: MP20 
URL:https://www.pharmajournalist.com/event/re%e2%80%a2work-deep-learning-in-healthcare-summit-boston/
LOCATION:InterContinental® Boston\, 510 Atlantic Avenue\, Massachusetts 02210
ORGANIZER;CN="RE%E2%80%A2WORK":MAILTO:luke@re-work.co
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260515T052105
CREATED:20190404T072211Z
LAST-MODIFIED:20190404T072453Z
UID:20182-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:5th Precision CRISPR Genome Editing Congress
DESCRIPTION:Designed with CRISPR experts from AstraZeneca\, AbbVie\, Broad Institute\, Casebia\, Merck\, Amgen and academics worldwide\, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery\, safety\, precision\, and efficiency to further optimize the relevant areas of drug discovery\, functional screening & CRISPR-based cell & gene therapy. \n \n\nLearn about how CRISPR is working in a clinical setting and unique approaches to gene therapy\nDiscover advances in disease modeling and strategies improving validation of human biology\nUnderstand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox\nExplore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases\nDiscover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline\nParticipate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR\n\nWith 100+ thought-leaders converging\, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network. \nTo learn more about this event\, visit https://ter.li/tjkmgn
URL:https://www.pharmajournalist.com/event/5th-precision-crispr-genome-editing-congress/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260515T052105
CREATED:20190206T125335Z
LAST-MODIFIED:20190206T125335Z
UID:19387-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:NDD Europe 2019
DESCRIPTION:Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics \n \nMultiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success. \nNDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration\, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers. \nWith 70+ thought-leaders converging at NDD Europe\, this will be an unrivalled opportunity for you to gain the latest scientific insights\, have your peers review your research and grow your collaborator network.
URL:https://www.pharmajournalist.com/event/ndd-europe-2019/
LOCATION:Hilton Paris La Defense\, 2 Place de la Défense\, 92800\, Puteaux\, France\, France
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190523
DTSTAMP:20260515T052105
CREATED:20181214T110222Z
LAST-MODIFIED:20181214T110356Z
UID:18840-1558396800-1558569599@www.pharmajournalist.com
SUMMARY:3rd Annual Digi-Tech Pharma 2019
DESCRIPTION:Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019)\, will provide a platform to all its participants an opportunity to interact\, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced\, new strategies\, case studies and use of innovative ideas in the field of Digital Pharma IT. Also\, to stay updated on the latest trends in digital\, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/3rd-annual-digi-tech-pharma-2019/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
END:VCALENDAR